A recent article in the Capital Business Journal, a Washington Post publication, about diversifying the local economy included information about how Children’s National is using data to help improve care for children with chronic conditions like sickle cell disease.
Read the article
Want the latest Children's National news and stories as they happen? Sign up to get our News & Events releases by email.
Cellular therapy is a novel treatment for reducing infection and relapse in children with blood cancers.
Our blood and marrow transplant offers trials for cellular therapy to reduce infection and relapse in children with cancer
Each week, the Edward J. Miller, Sr. Blood Donor Center at Children’s National needs 100 whole blood donations and 35 platelet donations to provide our pediatric patients with life-saving surgeries and to nurse children back to health from cancer or sickle cell disease.
Dr. Susan Perrine-Faller, a hematologist and oncologist at Howard University, discusses research pertaining to sickle cell disease including the possible benefits of high levels of fetal hemoglobin, the oxygen-carrying pigment produced in the womb, on preventing red blood cells to sickle in adolescent and adult patients.